Matches 1 - 50 out of 152 1 2 3 4 >


Match Document Document Title
US20100305076 METHODS OF TREATMENT FOR ULCERATIVE COLITIS  
Disclosed herein are new treatments for moderate ulcerative colitis in various subject subgroups. The various subject subgroups include Caucasians, non-smokers, subjects under the age of about 65...
US20090062241 Highly porous, fast-disintegrating solid dosage form and its way of manufacturing comprising the preparation of a powder and a freezedrying step  
The invention relates to a method of manufacture of fast-disintegrating solid dosage forms, characterized in that one or more structure building components in mixed solid powder form are dosed...
US20130273156 ORAL PHARMACEUTICAL TABLET FOR CONTROLLED RELEASE OF MESALAZINE AND PROCESS FOR OBTAINING IT  
The invention provides an oral pharmaceutical tablet for controlled release of mesalazine or a pharmaceutically acceptable salt thereof as active ingredient with a core and a gastro-resistant...
US20120213772 Metabolic biomarkers of Crohn's Disease  
The invention provides for a method for identifying a biomarker in a fecal sample of a subject in need of such identification comprising: determining whether a fecal sample collected from a...
US20150056275 CONTROLLED-RELEASE SOLID DOSAGE FORMS OF MESALAMINE  
Described are controlled-release solid dosage forms of mesalamine. In one aspect of the invention the controlled-release solid dosage forms of mesalamine are capsules comprising a plurality of...
US20150150852 TREATMENT AND PREVENTION OF DENGUE VIRUS INFECTIONS  
Methods and pharmaceutical compositions for treating viral infections, by administering certain 2-aryl-benzothiazole or 2-heteroaryl-benzothiazole derivative compounds in therapeutically effective...
US20130231312 TREATMENT OF TYPE II DIABETES AND DIABETES-ASSOCIATED DISEASES WITH SAFE CHEMICAL MITOCHONDRIAL UNCOUPLERS  
This application discloses methods for treating, preventing and/or alleviating the symptoms of type II diabetes and diabetes-related disorders or complications. The invention provides a novel...
US20110033486 GENE EXPRESSION MARKERS FOR CROHN'S DISEASE  
The present invention relates to methods of gene expression profiling for inflammatory bowel disease pathogenesis, in which the differential expression in a test sample from a mammalian subject of...
US20130231310 MESALAMINE SUPPOSITORY  
The present invention relates to a mesalamine rectal suppository designed to provide improved comfort of use. One embodiment of the invention is a mesalamine rectal suppository-comprising...
US20110171232 METHODS OF TREATING AUTOIMMUNE DISEASES CAUSED BY SMALL INTESTINAL BACTERIAL OVERGROWTH  
Disclosed is a method of diagnosing autoimmune diseases, such as multiple sclerosis and systemic lupus erythematosus, which involves detecting the presence of small intestinal bacterial overgrowth...
US20150164920 CONTROLLED RELEASE FORMULATION COMPRISING MESALAMINE  
The present invention refers to a controlled release pharmaceutical formulation in solid form comprising Mesalamine. The invention also contemplates the preparation of the said formulation and its...
US20110288058 Methods for Preventing or Reducing Colon Carcinogenesis  
The present invention is directed in part to methods of preventing or reducing colon carcinogenesis comprising administering to a patient at risk of colorectal cancer, a pharmaceutical preparation...
US20150148318 METHOD FOR INHIBITING GROWTH OF CANCER CELLS  
A method of inhibiting the growth of cancer cells is disclosed in which cancer cells that contain an enhanced amount relative to non-cancerous cells of one or more of phosphorylated mTOR, Akt1,...
US20150140133 IN SITU CONTROLLED RELEASE DRUG DELIVERY SYSTEM  
A system is described for long-term controlled release delivery of a drug or a therapeutic agent. According to the invention, one or more drugs or therapeutic agents contained in microspheres are...
US20150150797 PELLET FORMULATION FOR THE TREATMENT OF THE INTESTINAL TRACT  
An orally administrable pharmaceutical pellet formulation for the treatment of the intestinal tract is disclosed, which comprises a core and an enteric coating, the core including, as a...
US20130309311 PELLET FORMULATION FOR THE TREATMENT OF THE INTESTINAL TRACT  
An orally administrable pharmaceutical pellet formulation for the treatment of the intestinal tract is disclosed, which comprises a core and an enteric coating, the core including, as a...
US20130189356 PELLET FORMULATION FOR THE TREATMENT OF THE INTESTINAL TRACT  
An orally administrable pharmaceutical pellet formulation for the treatment of the intestinal tract is disclosed, which comprises a core and an enteric coating, the core including, as a...
US20130177650 PELLET FORMULATION FOR THE TREATMENT OF THE INTESTINAL TRACT  
An orally adminsterable pharmaceutical pellet formulation for the treatment of the intestinal tract is disclosed, which comprises a core and an enteric coating, the core including, as a...
US20120308659 PELLET FORMULATION FOR THE TREATMENT OF THE INTENSTINAL TRACT  
An orally adminsterable pharmaceutical pellet formulation for the treatment of the intestinal tract is disclosed, which comprises a core and an enteric coating, the core including, as a...
US20110212161 TREATMENT SKIN DISORDERS  
Disclosed are a composition and a method for treating skin disorders, including rosacea, pityriasis rosea, erythema, rhinophyma, and rosacea-associated disorders including pimples, papules,...
US20130022681 GRANULES FOR PHARMACEUTICAL PREPARATIONS, METHODS AND APPARATUS FOR THEIR PRODUCTION  
Disclosed are improved granular pharmaceutical preparations, together with improved methods and apparatus for preparation of granules for use in such preparations. Such methods are especially...
US20100048519 METHODS OF TREATMENT FOR ULCERATIVE COLITIS USING AMINOSALICYLATE  
Disclosed herein is a new treatment for ulcerative colitis in male mammalian subjects. Further disclosed are increased dosages of an aminosalicylate composition for treatment of moderate...
US20120093759 Medical Devices, Wound Dressings, and Methods for Dressing Wounds  
Medical devices, wound dressings, and methods of dressing wounds are described. Devices and methods using silicone and pharmaceutically active agents are described. Devices including covers and...
US20140141077 COMPOSITION FOR USE IN TREATING AND PREVENTING INFLAMMATION RELATED DISORDER  
The present invention is related to a use for treating and preventing inflammation related disorder of a composition containing a drug and hyaluronic acid (HA) or HA mixture, whereas the HA or the...
US20150164921 CHEMOPREVENTION OF COLORECTAL CANCER  
In the present invention, a new combination is disclosed comprising (i) 5-aminosalicylic acid (5-ASA) or a derivative thereof, or a pharmacologically acceptable salt thereof, and (ii) a group D...
US20050232980 Transdermal chondroitin and glucosamine delivery system and method of use  
Method and composition for a formulation applied to the skin in a transdermal delivery system to address discomfort from various musculoskeletal conditions. The formulation comprises 0.01% to 20%...
US20150183800 GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS AND METHODS RELATING THERETO  
GnRH receptor antagonists are disclosed which have utility in the treatment of a variety of sex-hormone related conditions in both men and women. The compounds of this invention have the...
US20110311631 CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION WITH RESISTANCE AGAINST THE INFLUENCE OF ETHANOL EMPLOYING A COATING COMPRISING A POLYMER MIXTURE AND EXCIPIENTS  
The invention relates to a controlled release pharmaceutical composition, comprising a core, comprising a pharmaceutical active ingredient, whereby the core is coated by an ethanol resistance...
US20090036414 Mesalamine Formulations  
Disclosed are oral dosage forms comprising an effective amount of mesalamine, wherein the dosage form has a dissolution profile such that greater than 5 wt % of the total weight of the mesalamine...
US20100136125 METHOD OF TREATING INFLAMMATORY BOWEL DISEASE  
Methods are disclosed for treating patients suffering from inflammatory bowel disease, including ulcerative colitis or Crohn's disease, by administering an oral or enema dosage form containing at...
US20140255322 SILOXANE POLYMER AND ACTIVES  
A siloxane polymer base that is useful as an excipient for many variable materials that can be compounded into it. Also disclosed are a method for the preparation of such bases, and another method...
US20140309200 Methods and Compositions for Enhanced Drug Delivery to the Eye and Extended Delivery Formulations  
The present invention comprises compounds and compositions thereof for enhanced drug delivery. Pro-drug and double pro-drug derivatives of corticosteroids non-steroid anti-inflammatory drugs...
US20120082634 TREATMENT FOR DYSLIPIDEMIA  
The present invention relates to compounds, and compositions, useful for treating dyslipidemia.
US20140193492 METHOD FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION COMPRISING 5-AMINOSALICYLIC ACID FOR USE IN TREATMENT OF ULCERATIVE COLITIS AND CROHN'S DISEASE  
The present invention concerns a new method of preparing granules comprising 5-aminosalicylic acid and a new method of preparing a pharmaceutical composition for the treatment of ulcerative...
US20130195980 METHOD FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION COMPRISING 5-AMINOSALICYLIC ACID FOR USE IN TREATMENT OF ULCERATIVE COLITIS AND CROHN'S DISEASE  
The present invention concerns a new method of preparing granules comprising 5-aminosalicylic acid and a new method of preparing a pharmaceutical composition for the treatment of ulcerative...
US20120202738 THERAPY FOR ENTERIC INFECTIONS  
There is disclosed herein a composition for treating gastrointestinal or neurological disorders, constipation, functional constipation, irritable bowel syndrome, diverticulitis, travelers...
US20130296283 POLYMORPHS OF DONEPEZIL SALTS, PREPARATION METHODS AND USES THEREOF  
Preparation methods of mesylate, para-toluenesulfonate, succinate, tartrate, sulphate, nitrate, phosphate, salicylate, fumarate, maleate, gallate, acetylsalicylate, benzenesulphonate, citrate,...
US20130090314 SOLID STATE FORMS OF TAPENTADOL SALTS  
Provided herein are novel solid state forms of tapentadol salts, process for their preparation, pharmaceutical compositions, and method of treating thereof. The tapentadol salts include an...
US20110071120 SOLID STATE FORMS OF TAPENTADOL SALTS  
Provided herein are novel solid state forms of tapentadol salts, process for their preparation, pharmaceutical compositions, and method of treating thereof. The tapentadol salts include an...
US20090233888 TREATMENT OF DISEASE CONDITIONS THROUGH MODULATION OF HYDROGEN SULFIDE PRODUCED BY SMALL INTESTINAL BACTERIAL OVERGROWTH  
The present invention relates to the treatment of a wide array of diseases and physiologic conditions based on modulating the level of hydrogen sulfide (H2S) in the body by at least partially...
US20120046244 DUAL FUNCTIONING IONIC LIQUIDS AND SALTS THEREOF  
Disclosed herein are ionic liquid compositions comprising active pharmaceutical, biological, and nutritional compounds, and methods of use. Further disclosed are compositions of matter including...
US20100105639 MESALAMINE SUPPOSITORY  
The present invention relates to a mesalamine rectal suppository designed to provide improved comfort of use. One embodiment of the invention is a mesalamine rectal suppository comprising...
US20110071117 COMBINATIONS OF ANTIOXIDANTS AND ANTI-INFLAMMATORY DRUGS IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE  
Disclosed herein are compositions comprising 5-aminosalicylic acid (5-ASA), or a pharmaceutically acceptable salt thereof and an antioxidant, or a pharmaceutically acceptable salt thereof. Also...
US20100255117 METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER  
The instant invention provides methods and compositions for the treatment of cancer.
US20130202691 MODIFIED STARCH DERIVATIVE-BASED MATRIX FOR COLON TARGETING  
A controlled-release oral pharmaceutical composition of at least an active agent, including: a) a lipophilic matrix consisting of lipophilic compounds and/or amphiphilic compounds; and b) an...
US20140073614 PHARMACEUTICAL AND FOOD COMPOSITIONS FOR PREVENTING OR TREATING DIABETES OR OBESITY  
The present invention relates to pharmaceutical and food compositions for preventing or treating diabetes or obesity, and more particularly to pharmaceutical compositions and functional foods for...
US20130281413 Salicylate Conjugates Useful For Treating Metabolic Disorders  
The present invention is directed to methods for treating metabolic disorders with compounds that are conjugates. The conjugates of the present invention are comprised of salicylic acid,...
US20130225539 METHOD FOR PRODUCING CRYSTALLINE 5-AMINOSALICYLIC ACID  
The invention relates to a method for producing crystalline 5-aminosalicylic acid with a particularly high tap and/or bulk density.
US20140370083 5-AMINOSALICYLIC ACID CAPSULE FORMULATION  
A dosage form comprising a capsule containing one or more tablets of 5-aminosalicylic acid or a salt thereof as an active ingredient where each of the one or more tablets is enterically coated is...
US20140141075 5-AMINOSALICYLIC ACID CAPSULE FORMULATION  
A dosage form comprising a capsule containing one or more tablets of 5-aminosalicylic acid or a salt thereof as an active ingredient where each of the one or more tablets is enterically coated is...

Matches 1 - 50 out of 152 1 2 3 4 >